COVID-19 News

  • The Race to Future-Proof Coronavirus Vaccines

    We keep hoping it’s all over. But sadly, the race against the coronavirus is still very much on. And it’s a long one.

  • Long COVID changed his life. Now he's part of a study looking at the scope of the problem in Sask.

    Tens of thousands of people in Saskatchewan could have long COVID.

  • App from Saskatoon researchers helps people with Long COVID

    Researchers with the Vaccine and Infectious Disease Organization (VIDO) have launched an app that aims to improve the lives and find unanswered questions of people living with Long COVID in the province.

  • What do we know about the Omicron subvariant BA.2?

    The Dose: So what do we know about this Omicron subvariant? We find out from Angela Rasmussen, a virologist at the University of Saskatchewan's Vaccine and Infectious Disease Organization (VIDO).

  • Inside the University of Saskatchewan's Vaccine and Infectious Disease Organization

    Home to one of Canada's largest biosafety labs, VIDO was one of the first in the country to isolate SARS-CoV-2.

  • Famed virologist Angela Rasmussen on Omicron’s origins, what’s next for the pandemic

    Famed virologist Angela Rasmussen talks to Adrienne Arsenault about the origins of Omicron, what’s next for the COVID-19 pandemic and the death threats she’s received since taking over a top lab in Saskatoon.

  • Previous infection poor protection against Omicron: U of S study

    "This is a new variant. It needs better antibody levels, and the best way to get those antibodies is from vaccines.”

  • Makers of Sask. COVID shot watch boosters and trials abroad

    VIDO is set to launch a trial in Uganda, part of an effort to expand vaccine access to low and middle-income countries.

  • The Omicron Variant Is a Mystery. Here’s How Science Will Solve It

    So far, panic about the new Covid variant has outpaced actual information. Here’s what scientists around the world are trying to uncover.

  • The team of scientists guarding Canada against COVID variants—'the known unknown'

    The Coronavirus Variants Rapid Response Network will serve as Canada’s early warning system for variants that could hurl us back into pandemic misery

  • VIDO running vaccine trial in Africa as Omicron variant spreads

    VIDO director and CEO Dr. Volker Gerdts tells Global News Morning they will trial their Saskatoon-made COVID-19 vaccine in Africa — and gives his thoughts on the Omicron variant.

  • The animal kingdom is full of coronaviruses. Here’s what that means for COVID’s future.

    Like the flu, SARS-CoV-2 is poised to keep jumping between people and animals.

  • Saskatoon researcher to study vaccine protection in vulnerable people

    A project at VIDO at the University of Saskatchewan will examine how COVID-19 vaccines provide protection from variants of concern.

  • VIDO virologist explains COVID-19 vaccine protections, need for booster shots and more

    Researcher says data shows booster shot could help elderly, immunocompromis

  • COVID-19 and animal populations

    While the importance of monitoring emerging variants in human populations is top of mind for many, there is also a need to monitor mutations in animal populations, says Arinjay Banerjee, research scientist at VIDO.

  • Delta, Delta, Delta with Dr. Angie Rasmussen

    Why is the delta variant a game-changer? Dr. Angie Rasmussen discusses why the delta variant is so transmissible and how it should change our approach to COVID-19 in general.

  • The coronavirus is rife in common US deer

    Survey results show that many white-tailed deer, a familiar sight on US lawns and golf courses, have antibodies to the virus that causes COVID-19.

  • Researchers say many questions left to answer about long COVID

    Preparing the province's health care system for what could be thousands of people experiencing symptoms not really understood is tricky, but that's what the SHA is trying to do.

  • VIDO vaccine hopefuls hold out for hometown COVID-19 study

    It’s been just over a month since VIDO issued a call out for volunteers to participate in its local COVAC-2 COVID-19 clinical trials.

  • Hospitals of Regina Foundation invests $150K in VIDO lab

    The head of the University of Saskatchewan’s VIDO said he’s very appreciative of a new investment in the lab and said it will go towards keeping COVID-19, and future pandemics, at bay.

  • VIDO research provides insight into possible long-term health impacts associated with COVID-19

    One of the newest scientists at Vaccine and Infectious Disease Organization published new research on potential lasting effects of COVID-19.

  • Canada monitoring 'whole slew' of variants, says chief public health officer

    Chief public health officer Dr. Theresa Tam says the latest variant of interest in the COVID-19 pandemic has popped up in Canada in small numbers, but it's too early to know how widespread it is or what impact it could have.

  • Promising first phase for VIDO vaccine development

    Video from Global Saskatoon Morning

  • Saskatchewan-made COVID-19 vaccine reaches 'critical step' in testing

    VIDO is now launching a call for more adult volunteers in Saskatoon who have yet to receive an approved shot.

  • Why mixing Pfizer and Moderna vaccines could help Canada end the pandemic sooner

    Mixing doses can protect more Canadians from COVID-19 now — and fight new variants

  • Two doses of vaccine highly effective against Delta variant, U.K. officials say

    Experts say it's absolutely vital to get the second dose of a two-dose series vaccine.

  • We may never know where the virus came from. But evidence still suggests nature

    From the moment the novel coronavirus, SARS-CoV-2, emerged in Wuhan, China, scientists and the broader public have sought answers to some fundamental questions: Where did this virus come from? How did the pandemic start?

  • Opinion: Vaccines didn' stop the Yankees COVID-19 oubreat. But the case proves how well they work

    The Yankees outbreak is a case study showing how well the vaccines are working.

  • Can we create a universal vaccine for future coronaviruses? These Canadian scientists want to

    In the middle of the COVID-19 pandemic, researchers in Saskatoon are suiting up for another fight.

  • Saskatchewan researchers investigate long-term health effects of COVID-19

    The long-term health effects of COVID-19 remain unclear, something researchers in Saskatchewan are trying to figure that out.

  • $59M in federal funding a 'recognition of VIDO's global prominence'

    "There is some investments that have a lot of impact, more than others sometimes," said federal minister Melanie Joly. "This is one; when looking back in 10 years, we'll see that was a really good decision."

  • VIDO on new federal funding, vaccine trial

    VIDO Director and CEO Dr. Volker Gerdts joins Global News Morning to discuss where $59 million in federal funding will go to, along with an update on their vaccine trial.

  • Education key to vaccine acceleration

    As someone who has dedicated his professional life to fighting life-threatening diseases, Dr. Volker Gerdts knows the biggest impediment to getting back to normal are those who are hesitant or refuse to be vaccinated against COVID-19.

  • Three COVID-19 vaccine prototypes are being tested in Halifax

    .Angelo George believes he could be fully vaccinated against COVID-19 with a Canadian prototype vaccine dubbed COVAC-2 being studied as part of a vaccine trial underway in Halifax.

  • Researchers racing to develop one vaccine for all coronaviruses

    As vaccines roll out across the globe to protect against COVID-19 and its known variants, researchers around the world are in a race to find a universal vaccine that could protect against the current strain of the coronavirus as well as future ones.

  • Three Canadian COVID-19 vaccines are under clinical trials in Halifax. Here’s why one man is volunteering to take the shot

    Pointing at the empty Saint Mary’s University campus, Angelo George smiled. “Two years ago, this place where we are right now would be busy with people,” said George, who is a PhD student studying astronomy at Saint Mary’s University.

  • 'Whole situation is unsettling:' How COVID-19 variants came to dominate Regina

    "The number of cases and how quickly the cases increased is remarkable compared to what we've seen before with our established public health measures."

  • VIDO takes steps forward in COVID-19 vaccine clinical trials

    Saskatchewan scientists are stepping up to help Canada and the rest of the world get back to the way life was. Kyle Benning sits down with VIDO director to discuss the progress of its homegrown vaccine.

  • No Nonsense with Pamela Wallin

    Producing Canadian vaccines in-house is key to beating the pandemic. Dr. Volker Gerdts gives us a look at VIDO’s expansion plans and an update on the clinical trials currently underway for their made-in-Saskatoon vaccine.

  • Shaping Saskatchewan: Dr. Volker Gerdts focused on developing COVID-19 vaccine

    Dr. Volker Gerdts’ focus right now is on vaccine development for COVID-19.

  • VIDO awaits federal decision for 'pandemic centre' ambitions

    The organization has earned much attention for its work on a COVID-19 vaccine, which is in early human trials.

  • COVID-19 sparks changes in how vaccines are developed

    Learning how to speed up work during the pandemic emergency is expected to also benefit the animal health field

  • Sask. government pledges $15M to VIDO-InterVac if feds also commit money for research facility

    VIDO is working to secure funds for a new Level 4 containment laboratory

  • City committee gives greenlight for Saskatoon-based pandemic research centre

    During a committee meeting Tuesday, city councillors gave the green light for a plan to help fund a proposed pandemic research centre based in Saskatoon.

  • City council set to back U of S 'pandemic centre' ambitions

    Saskatoon city council is set to attach its name, and potentially its money, to the University of Saskatchewan’s bid to establish a national pandemic response centre.

  • When the next pandemic hits, scientists aim to have a vaccine already. Here's how

    Researchers are trying to develop more universal vaccines to be ready for the next coronavirus

  • Clinical trials start for USask’s COVID-19 vaccine candidate

    Clinical trials have begun for another Canadian-made COVID-19 vaccine candidate.

  • Made in Sask. vaccine enters human trials

    It's a global pandemic, but there is a local vaccine. As we focus on supply problems with vaccines from afar, VIDO at the University of Saskatchewan is moving forward with human trials of its own COVID-19 vaccine.

  • Saskatoon lab expects to start producing vaccines in early 2022

    Dr. Volker Gerdts is hopeful that new federal announcements on improving long-term vaccine production are a sign the country is learning a lasting lesson.

  • VIDO vaccine in clinical trials, production facility operational next year

    Canada shared new details Tuesday about plans to manufacture COVID-19 vaccines at home — and Saskatchewan is a key player.

  • Saskatchewan-made COVID vaccine begins clinical trial

    The made-in-Saskatchewan COVID-19 vaccine has entered clinical trials.

  • Scientists racing to understand new COVID-19 variants and whether they will derail vaccination efforts

    Researchers warn future sets of mutations could evade current SARS-CoV-2 vaccines

  • VIOO'S New COVID-19 Vaccine Uses Proven Technology

    The Director and CEO of VIDO says the COVID-19 vaccine it's preparing to test in humans was developed using a technology that is proved to be safe, reliable and cost effective.

  • Canada building facilities to make vaccines for COVID-19 and other viruses

    Vaccine independence is important, because relying on relationships with other countries doesn’t always work.

  • Saskatoon lab CEO details human trials for Canadian COVID-19 vaccine that doesn't need 'complicated storage'

    As the rollout of a limited supply of Moderna and Pfizer's COVID-19 vaccines continues to gain steam across the country, VIDO is expected to start delivering the first doses of its own vaccine candidate as part of a recently-approved human clinical trial.

  • VIDO-InterVac prepares for human trials with COVID-19 vaccine

    It’s the kind of start to a new year that researchers at VIDO-InterVac were hoping for. CEO Volker Gerdts says they are days away from the first human testing with the COVID vaccine they’ve been working on for months.

  • Saskatchewan scientists get green light to start COVID-19 vaccine trial

    Scientists got an early Christmas present this week when they got the green light to begin testing their COVID-19 vaccine in humans.

  • CEO of Saskatoon lab explains how COVID-19 vaccines have been developed so fast

    CTV News spoke with Volker Gerdts to learn about how these vaccines have been developed so fast, whether they present any new safety concerns, and the status of VIDO-InterVac’s own vaccine candidate.

  • Saskatoon-made COVID-19 vaccine applying to start clinical trials

    A day after the Pfizer COVID-19 vaccine was approved for use in Canada, VIDO-InterVac is hitting a milestone with their Saskatoon-made vaccine – filing an application to start human clinical trials.

  • The Morning Edition - Sask with Stefani Langenegger: Check-in with VIDO-InterVac

    Since the pandemic was first announced, many people have anxiously anticipated a vaccine as a solution to the problem of COVID-19. VIDO provides an update on its efforts to come up with a made-in-Canada answer to COVID-19.

  • Alberta at Noon with Judy Aldous: Your vaccine questions answered

    Virologist Dr. Darryl Falzarano joined Alberta@noon to answer questions about COVID-19 vaccines.

  • Podcast: No Nonsense with Pamela Wallin

    Coronavirus Vaccine Update with Dr. Volker Gerdts of VIDO InterVac (11.27.2020)

  • Researcher hopes Canada is better prepared for vaccine manufacturing in the future

    Dr. Volker Gerdts discusses vaccine manufacturing on CBC Power & Politics

  • USask’s Vido-InterVac nearing human clinical trials for COVID-19 vaccine

    VIDO-InterVac is in the final stages before the COVID-19 vaccine they are developing will be tested on people. After toxicology tests, Health Canada will need to approve the first two phases of clinical trials to ensure it is safe.

  • VIDO-InterVac seeking funding to establish national centre for pandemic research in Saskatchewan

    Facility's COVID-19 vaccine could start human clinical trials in December.

  • Saskatoon lab aims for human trials next month as vaccine race heats up

    VIDO-InterVac's director said the work will be valuable even if US companies cross the finish line for an approved COVID-19 vaccine.

  • YXE Underground podcast

    Research Technicians Andrea Kroeker and Jill Van Kessel sit down with host Eric Anderson to share what it’s like to play a role in such an important global initiative and how they deal with the pressure of their job.

  • Saskatoon's VIDO-InterVac becoming 'go-to' hub for COVID-19 research, says director

    Saskatchewan’s top vaccine researchers have been keeping busy. CEO and director Dr. Volker Gerdts said the VIDO-InterVac is testing COVID-19 vaccines, antiviral drugs and therapeutics for more than 70 companies in Canada and across the world.

  • A closer look at Canada's homegrown COVID-19 vaccine candidates

    Scientists across Canada are using a range of technologies to produce immunity against SARS-CoV-2

  • VIDO-InterVac update on COVID-19 antiviral funding, vaccine research

    VIDO-InterVac director Dr. Volker Gerdts joins Global News Morning for an update on their COVID-19 vaccine research, along with recent funding for antiviral research.

  • Saskatoon lab to test antiviral compounds' response to COVID-19

    VIDO-InterVac at the University of Saskatchewan has been awarded a grant of $830,000 to help collaborate with global research leaders on the response to fight COVID-19.

  • A COVID vaccine is just the start, complicated decisions ahead

    As cases of COVID-19 spike-up again across Canada, more questions are arising about a potential vaccine

  • Quirks & Quarks: Fast, effective and ethically distributed — what we need from a COVID vaccine

    With scientists promising a vaccine in record time, how do we know the results are safe? Dr. Alyson Kelvin talks with Quirks & Quarks host Bob McDonald.

  • A Virologist Explains The Realities Of Biomedical Research During A Pandemic

    Dr. Jason Kindrachuk, an infectious disease expert, examines the progress so far and the challenges that remain for researchers studying COVID-19 vaccines and treatments.

  • Podcast: No Nonsense with Pamela Wallin

    In this episode, Senator Wallin and Dr. Volker Gerdts discuss coronavirus vaccine development, the second wave and herd immunity.

  • How to vaccinate a planet

    What it will take to build the fastest inoculation program in history and defeat COVID-19

  • VIDO-InterVac one step from COVID-19 vaccine clinical trials

    VIDO-InterVac is one step away from getting the green light for clinical trials of their COVID-19 vaccine. Director Dr. Volker Gerdts tells us what that step is, and when trials could begin.

  • U of S research team uses comics, videos to make information about COVID-19 accessible

    A team of doctors, artists, engineers, and medical professionals collaborated on the COVID-19 informational comics and videos.

  • Podcast: Inside Canada's race for a COVID-19 vaccine

    A global race for a safe and effective COVID-19 vaccine is underway.

  • USask’s VIDO-InterVac partners with Canadian manufacturers to combat COVID-19

    The University of Saskatchewan’s VIDO-InterVac has partnered with Dalton Pharma Services (Dalton), as well as Biodextris, in the effort to develop a vaccine for COVID-19.

  • Sask. vaccine developer locks in Canadian manufacturers for human clinical trials

    The University of Saskatchewan's VIDO-InterVac has contracted two Canadian pharmaceutical companies to manufacture ingredients for its potential COVID-19 vaccine to be used in the first stages of human clinical trials.

  • Podcast: No Nonsense with Pamela Wallin

    In this episode, Senator Wallin and Dr. Volker Gerdts discuss the work currently being done by VIDO-InterVac at the University of Saskatchewan to develop a vaccine for COVID-19.

  • USask’s VIDO-InterVac team collaborating with other universities to develop COVID-19 vaccine

    The University of Saskatchewan’s VIDO-InterVac team is nearing human clinical trials for a COVID-19 vaccine being developed. They’re now collaborating with the University of Manitoba and Dalhousie University.

  • COVID-19 vaccine at VIDO-InterVac on track for human trials this fall

    Work on a COVID-19 vaccine continues to show encouraging results at Saskatoon’s VIDO-InterVac at the University of Saskatchewan.

  • Podcast: Volker Gerdts on the search for a vaccine

    Dr. Volker Gerdts was a guest on the Conference Board of Canada's Bright Future podcast. The episode covers vaccine development, Canada’s place in solving a global problem, and how VIDO-InterVac is positioning itself to be Canada’s pandemic centre.

  • On the verge

    In the uncertain reality of an ongoing global pandemic, anticipation is building around the development of a vaccine.

  • VIDO-InterVac shifts focus to hamsters in efforts to create COVID-19 vaccine

    CEO Dr. Volker Gerdts says VIDO-InterVac is now focusing on comparing the results in hamsters after demonstrating the vaccine's efficacy in ferrets.

  • Inside the Saskatoon lab developing a COVID-19 vaccine

    Dr. Volker Gerdts is already thinking about the next pandemic. The director and CEO of VIDO-InterVac and his team have been working on a vaccine for SARS-CoV-2, the novel coronavirus that causes COVID-19, since before it even had a name.

  • COVID-19 Vaccine Development in Canada

    Interview with Dr. Gerdts -- part of the COVID-19 Rebound Series Supported by Genome Canada on The Future Economy

  • Labs across Canada tracking COVID-19 mutations to understand which are circulating and compare internationally

    Laboratories say genetic changes will help find source of new cases when borders open

  • It can take 10 years to develop a vaccine. How do you do it in one? Inside Canada's race for a COVID-19 vaccine

    Dr. Darryl Falzarano is a vaccine hunter. Until the COVID-19 pandemic struck, his lab was focused on developing vaccines for camels against MERS.

  • Sask. research paves way for COVID-19 vaccine clinical trial

    Researchers at the University of Saskatchewan say early tests on a COVID-19 vaccine was effective in ferrets, which paves the way for a clinical trial.

  • Canadian vaccine candidate shows promising results

    Power & Politics speaks to Dr. Volker Gerdts, director at VIDO-InterVac.

  • Potential COVID-19 vaccine clears 'major milestone': Sask. researchers

    Research centre says candidate vaccine induced a 'strong immune response' in ferrets

  • Saskatoon company using plants to help search for COVID-19 vaccine

    A Saskatoon-based company best known for its research on medical cannabis is collaborating with leading vaccine researchers to see if plant cells can produce a key ingredient for a COVID-19 vaccine.

  • For Canada, Finding a Vaccine Will Only Be Part of the Equation

    As many provinces ease up on some coronavirus restrictions — notably in Quebec, which has decided to reopen some schools — the discussion about vaccines has been increasing.

  • VIDO-InterVac making progress on vaccine

    There are some promising early signs as researchers at the VIDO-InterVac develop a vaccine for COVID-19.

  • 'A race against the disease': Canadian researchers part of global effort to develop COVID-19 vaccine

    'We have a highly motivated team, and everybody is willing to step up and do as much as they can'

  • Progress in the development of VIDO-Intervac’s novel coronavirus vaccine

    Global News Morning Saskatoon Interview

  • The Canadian Search for a Vaccine

    The Bridge with Peter Mansbridge: The inside story of a busy research lab in Saskatoon and its part of a world wide race to stop a killer

  • On the front lines of the coronavirus-vaccine battle

    Canadian virologist Alyson Kelvin raced across the country to begin a collaboration with VIDO-InterVac to develop vaccines against COVID-19.

  • Sask. researchers say they successfully decontaminated N95 masks for reuse

    Interview on CBC Saskatchewan Weekend

  • SHA and VIDO-InterVac partner to decontaminate and reuse N95 masks

    In the face of a global shortage of N95 respiratory masks, the Saskatchewan Health Authority and VIDO-InterVac in Saskatoon have developed a way to decontaminate the masks and extend their single-use lifespan.

  • VIDO-Intervac to sterilize used N-95 masks for re-use, establishing emergency supply

    As the world faces supply issues for N-95 medical-grade respirator masks in the middle of the COVID-19 pandemic, the SHA and USask are striking a deal to create an emergency supply out of masks already in the province.

  • Ferrets to be tested for immunity after receiving COVID-19 vaccine says VIDO-InterVac Director

    Dozens of ferrets and hamsters at Saskatoon’s VIDO-InterVac will soon show scientists whether they have developed immunity to the COVID-19 virus.

  • Decouverte: Prévenir et guérir

    To counter the COVID-19 pandemic, humanity has no effective treatment or vaccine to date. Discovery followed three teams of researchers who are mobilizing to fill this gap.

  • Ferrets, hamsters will soon reveal whether Canadian vaccine bid has a shot

    Dr. Volker Gerdts estimates there are upwards of 200 ferrets at his vaccine research facility in Saskatoon right now, including a shipment of more than 100 recent arrivals. Not to mention dozens of hamsters.

  • Coronavirus: Saskatoon lab tests potential vaccine on ferrets

    A University of Saskatchewan lab says it is on the forefront of developing a vaccine for the novel coronavirus and a manufacturing lab to produce it.

  • A look at the search for a COVID-19 vaccine in Canada

    Thousands of scientists around the world are working on problems raised by the COVID-19 pandemic, including the search for a vaccine against the virus. Canadian researchers are part of that search.

  • How science is accelerating to try and catch up with COVID-19

    Canada needs its own vaccine for the novel coronavirus, says virologist Alyson Kelvin. 'If all countries are experiencing this at the same time, no one is going to be able to share with us.'

  • A look at research being done in Canada for a coronavirus vaccine

    Thousands of scientists around the world are working on problems raised by the coronavirus pandemic, including the search for a vaccine against the virus. Canadian researchers are part of that search.

  • COVID-19 – Accelerating Vaccine Development and Manufacturing

    As the COVID-19 outbreak rapidly evolves, work to develop a vaccine and to test antivirals and other therapeutics continues in parallel.

  • 'Lab in a box': Scientists race to expand coronavirus testing

    Transnational research team wants to create a system that will allow more people in rural areas be tested for COVID-19.

  • Saskatchewan researchers to help test possible COVID-19 vaccines

    Saskatchewan researchers are part of a team of looking for solutions in the fight against the new coronavirus, COVID-19.

  • How far are we from a coronavirus vaccine

    As we watch diagnoses of the new coronavirus disease increase globally and we hunker down to minimize transmission the world holds out hope for a new coronavirus vaccine.

  • Témoignages au coeur de la recherche sur le vaccin contre la COVID-19 en Saskatchewan

    À Saskatoon, le Centre de recherche sur les vaccins et les maladies infectieuses de l'Université de la Saskatchewan (VIDO-InterVac) est au centre de l’attention depuis plusieurs jours.

  • $12 M Awarded for New COVID-19 Vaccine Manufacturing Efforts

    s the COVID-19 outbreak continues to rapidly evolve, the federal government is announcing $23.3 million in total support for the University of Saskatchewan's VIDO-InterVac.

  • How a lab in Sask. that focuses on animals became Canada's $23M hope for a COVID-19 vaccine

    Finding a pan-coronavirus vaccine has never been a winning pitch for grant money — until now

  • Sask. researchers try to develop a vaccine and find treatments for COVID-19

    Host Garth Materie talks with the director of the University of Saskatchewan VIDO InterVac research centre looking to develop a vaccine for coronavirus.

  • How three Canadian research teams are battling the pandemic

    We don’t yet know how to prevent, treat and address all the ramifications of COVID-19, but many university-based researchers are trying. Canadian academics are working on dozens of research projects on the virus, with more to follow.

  • Interview with CBC Saskatoon Morning with Jen Quesnel

    Could the spread of viruses like COVID-19, become the new normal? Scott Napper is the Interim Associate Director of Research at VIDO-InterVac. He spoke with Saskatoon Morning's Jennifer Quesnel.

  • Vaccin pour le COVID-19 : Deux francophones font partie des recherches à Saskatoon

    La gestionnaire de projet Élodie Pastural et le vétérinaire Alain Fafard travaillent en équipe à l’institut de recherche VIDO-InterVac. Leur objectif : développer le plus rapidement possible un vaccin contre la COVID-19.

  • Feds pledge $23.3M for VIDO-InterVac amid COVID-19 pandemic

    The federal government has committed $23.3 million for the University of Saskatchewan’s Vaccine and Infectious Disease Organization — International Vaccine Centre (VIDO-InterVac).

  • Makers of 1st coronavirus vaccine in Saskatchewan get $28M in federal, provincial funding

    A Saskatoon lab that has created Canada’s first coronavirus vaccine – which is currently in the testing stage but still a long way from being manufactured – has now received $28 million from the federal and provincial governments since January.

  • Ottawa to fund existing coronavirus research projects

    Ottawa will fund existing research projects across Canada to improve the odds of finding vaccines and treatments against COVID-19, as well as invest in future vaccine-production capabilities.

  • Trudeau announces $23 million for VIDO-InterVac’s COVID-19 vaccine development

    With their SARS-CoV-2 vaccine currently in animal testing, the federal government is allocating $23 million to help support the next phases of clinical testing which includes a new manufacturing facility.

  • The economics of finding a vaccine for COVID-19

    Financial challenges to finding a coronavirus vaccine are significant but not insurmountable

  • COVID-19: U of S lab develops animal model for COVID vaccine testing

    The University of Saskatchewan’s Vaccine and Infectious Disease Organization-International Vaccine Centre (VIDO-InterVac) is the first Canadian lab to develop an animal model for COVID-19 vaccine testing.

  • VIDO-InterVac is finding a vaccine for COVID-19

    Director and CEO of VIDO-InterVac, Dr. Volker Gerdis, joins us to talk about how they are creating a vaccine.

  • Calgary Eyeopener with David Gray, Angela Knight

    We talk to Paul Hodgson, the associate director of the VIDO-InterVac lab at the University of Saskatchewan, about the race to find a vaccine for COVID-19.

  • Director Of The COVID-19 Vaccine Research Team Explains The Process & What's To Come

    COVID-19 was recently declared a pandemic by the World Health Organization. As we speak, a research lab in Canada has been working hard on a potential vaccine.

  • Two Canadian teams of scientists isolate coronavirus to speed research effort

    Two teams of Canadian scientists have isolated the coronavirus that causes COVID-19 and successfully reproduced it in the laboratory.

  • Saskatoon researchers develop potential covid-19 vaccine

    Since early January, scientists in one corner of the University of Saskatchewan have been studying the way Covid-19 infects people. They work at the Vaccine Infectious Diseases Organization International Vaccine Centre.

  • Canada's First Coronavirus Vaccine Made In Saskatchewan Is Now In Testing Stages

    While the world is making monumental changes in the face of the COVID-19 pandemic, a vaccine is being worked on in Canada. And now, a Saskatchewan coronavirus vaccine is officially in the testing stages.

  • Saskatoon research lab gets $200,000 to find COVID-19 vaccine

    The province is providing researchers at the University of Saskatchewan with $200,000 to help find a vaccine for COVID-19.

  • Sask. government gives $200,000 for COVID-19 vaccine research

    A Saskatoon lab is receiving $200,000 from the provincial government to work on the search for a COVID-19 vaccine as global health officials officially label the situation a pandemic.

  • Ferrets, a Saskatoon lab and the leading edge of the race for a coronavirus vaccine

    A Saskatoon-based lab is at the forefront of the global race to develop a vaccine for the novel coronavirus, COVID-19.

  • U of S team gets federal dollars to develop COVID-19 vaccine

    Saskatchewan researchers have been tapped to assist in a global effort to find a vaccine for COVID-19, the novel coronavirus that has infected more than 100,000 people around the globe since it was first detected in central China in 2019.

  • From ferrets to mice and marmosets, labs scramble to find right animals for coronavirus studies

    Ferrets are among the animals researchers are infecting with the Covid-19 virus as they search for a suitable species to use in tests of vaccines and drugs.

  • Saskatoon microbiologist says hand washing is the best protection against the coronavirus

    Saskatoon microbiologist says hand washing is the best protection against the coronavirus

  • CBC The Current: Coronavirus vaccine development

    What will it take to get a coronavirus vaccine out quickly, and safely?

  • New coronavirus may be no more dangerous than the flu despite worldwide alarm: experts

    The apparent high initial mortality rates have shrunk as the number of infections grows, and many of the infected appear to have mild or no symptoms

  • It could be up to three years before a coronavirus vaccine is accessible, Canadian scientists say

    The team at the International Vaccines facility are in preliminary stages of developing a prototype and say it could be a year before the vaccine is ready to test on humans

  • Canadian scientists join the global race to find a vaccine for the coronavirus

    A group of scientists in Saskatchewan is working to create a vaccine that would protect against multiple strains of coronavirus, including the latest that originated in Wuhan, China, and triggered a global health emergency this month.

  • Breaking down the coronavirus outbreak

    The coronavirus has been causing concern around the world, including Canada and Saskatchewan. But with any outbreak, there's just as much misinformation and credible information.

  • Go inside the high-security lab where scientists search for a coronavirus vaccine

    Researchers at VIDO-InterVac take us inside a Level 3 lab where they work with deadly viruses

  • Saskatchewan lab joins global effort to develop coronavirus vaccine

    As Canadian public health agencies prepare to deal with a new viral illness, a specialized lab in Saskatoon is using its research on different strains of the coronavirus to help develop a vaccine

  • U of S researchers get green light to work on coronavirus vaccine

    University of Saskatchewan researchers are developing a vaccine for a deadly new type of coronavirus originating from China.

  • Saskatoon lab joins race for coronavirus vaccine

    Saskatchewan’s low level of risk for being affected by the new coronavirus outbreak isn’t stopping one of the province’s laboratories from jumping into the vaccine race.

  • Sask. researchers aiming to develop a vaccine for coronavirus outbreak in China

    Researchers at the University of Saskatchewan are aiming to develop a vaccine that could help address an outbreak of coronavirus that has killed six people in China.

  • Researchers at VIDO working on vaccine for deadly new coronavirus

    Interview on CBC Saskatoon Morning's Jennifer Quesnel